Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance
The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Abstract
Reactive oxygen species (ROS) are emerging as key effectors in signal transduction. This role of ROS is especially evident in the pathways leading to programmed cell death (PCD) elicited in response to certain stress stimuli and cytokines. In these pathways, cytotoxic ROS signaling appears to be mediated in part by activation of the c-Jun-N-terminal kinase (JNK) mitogen-activated protein kinase (MAPK) cascade. Another pathway that is under ROS-mediated control in some systems is that leading to activation of transcription factor nuclear factor-kappa B (NF-kappaB), which is a central regulator of immunity, inflammation and cell survival. Remarkably, new evidence has unveiled the existence of a reciprocal, negative control that NF-kappaB exerts on ROS and JNK activities. This NF-kappaB-imposed restraint on ROS and JNK signaling is crucial for antagonism of PCD elicited by the proinflammatory cytokine tumor necrosis factor (TNF)alpha and likely other triggers. Effectors of this antagonistic cross-talk between NF-kappaB and ROS/JNK pathways have recently been identified. Because of the key roles that the prosurvival function of NF-kappaB plays in organismal physiology and disease, gaining a further mechanistic understanding of this cross-talk and NF-kappaB-dependent survival may be key to developing new therapies for the treatment of widespread human illnesses, such as cancer and chronic inflammatory conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROS have been shown to activate proinflammatory and MAPK signaling cascades, subsequently leading to various biological responses including cell death or dysfunction [43–45].”
From Nrf2 in keratinocytes modulates UVB-induced DNA damage and apoptosis in melanocytes through MAPK signaling (2017) · cites this paper as [43]
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745 · cited 2×
“Soon after the initial discovery of NF-kB, several studies implicated ROS as central effectors for activation of this factor by an array of triggers (Schreck et al., 1991; reviewed in Baeuerle and Henkel, 1994; Flohe et al., 1997; Gloire et al., 2006).”
BackgroundDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388 · cited 7×
“…adenine dinucleotide phosphate (reduced form) (NADPH) oxidases and other enzymes, including those participating in arachidonic acid metabolism such as lipoxygenases (LOXs) and cyclooxygenases (COXs) (Curtin et al., 2002; Lambeth, 2004; Victor et al., 2004; Balaban et al., 2005; Storz, 2006).”
BackgroundInfluentialSignal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237 · cited 15×
“…and the extracellular-regulated kinase (ERK) pathways, the JNK pathway transduces signals initiated by an array of stimuli via sequential phosphorylation of distinct kinase modules, ultimately eliciting an appropriate biological response to these stimuli (Davis, 2000; Karin and Gallagher, 2005).”
BackgroundInfluentialHayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842 · cited 32×
“Oncogene with this notion, suppression of NF-kB activity by either knockout of rela or ikkb or by overexpression of the IkBa super-repressor (a hyperactive variant of the natural inhibitor IkBa) markedly impairs normal downregulation of TNFa-elicited JNK signaling (De Smaele et al., 2001; Tang et al., 2001; Papa et al…”
BackgroundInfluentialSchreck, R., Rieber, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816 · cited 3×
“Soon after the initial discovery of NF-kB, several studies implicated ROS as central effectors for activation of this factor by an array of triggers (Schreck et al., 1991; reviewed in Baeuerle and Henkel, 1994; Flohe et al., 1997; Gloire et al., 2006).”
BackgroundNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
NOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125 · cited 2×
“…adenine dinucleotide phosphate (reduced form) (NADPH) oxidases and other enzymes, including those participating in arachidonic acid metabolism such as lipoxygenases (LOXs) and cyclooxygenases (COXs) (Curtin et al., 2002; Lambeth, 2004; Victor et al., 2004; Balaban et al., 2005; Storz, 2006).”
BackgroundReactive oxygen species in cell signaling
Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,927 · cited 3×
“These include cytosolic phospholipase A2 (cPLA2), ER-associated, NADPH cytochrome P450 reductase and plasma membrane NADPH oxidase (Thannickal and Fanburg, 2000; Sauer et al., 2001; Haddad, 2002; Jäättelä and Tschopp, 2003; Lambeth, 2004; Victor et al., 2004; Nakano et al., 2006; Papa et al.,…”
BackgroundSignalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793 · cited 5×
“…of the TNF-R family such as BAFF-R and RANK – controlling B lymphopoiesis and osteoclastogenesis, respectively, through mechanisms that depend on NF-kB – as well as of DRs in this family, such as Fas (CD95) (Aggarwal, 2003; Kucharczak et al., 2003; Bottero et al., 2006; Claudio et al., 2006).”
BackgroundInfluentialInduction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738 · cited 2×
“This complex then leads to activation of NF-kB, which sustains cell survival (Micheau and Tschopp, 2003; Wajant et al., 2003; Schneider-Brachert et al., 2004; Papa et al., 2006).”
BackgroundNF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430 · cited 1×
“…discovery that the growth of certain primary and metastatic tumors relies on an NF-kB-driven inflammatory reaction engulfing the cancerous tissue (Pikarsky et al., 2004; Maeda et al., 2005; Karin, 2006), may provide yet another link between cancer progression and the inhibitory activity of NF-kB…”
BackgroundTumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359 · cited 12×
“The study showed that TNFa-induced sustained JNK signaling accelerates turnover of the caspase-8 antagonist, c-FLIPL, through a mechanism that involves activation of the E3 ubiquitin ligase, Itch, by direct JNK-mediated phosphorylation (Wajant et al., 2003; Chang et al., 2006; Karin, 2006).”
BackgroundInfluentialCellular response to oxidative stress: Signaling for suicide and survival*
Martindale, J. L., & Holbrook, N. J. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10119 · Cited by 2,297 · cited 8×
“…and Holbrook, 2002; Kabe et al., 2005); whereas in the nucleus, DNA binding and transcriptional activity of NF-kB dimers require the presence of a reducing environment, created in part through the action of Trx (Hirota et al., 1999; Haddad, 2002; Martindale and Holbrook, 2002; Kabe et al., 2005).”
BackgroundInfluentialIntroduction to NF-κB: players, pathways, perspectives
Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209954 · Cited by 2,222 · cited 10×
“…et al., 2003; Hayden and Ghosh, 2004; Bottero et al., 2006; Claudio et al., 2006; Courtois and Smahi, 2006; Karin, 2006; Kim et al., 2006; Mattson and Meffert, 2006; Perkins and Gilmore, 2006) Here, we focus on recent discoveries that have unveiled how NF-kB and ROS engage in a mutual cross-talk.”
BackgroundInfluentialHoller, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938 · cited 3×
“Of interest, participation of RIP1 in induction of ROS (and programmed necrosis) depends on its kinase activity, a function not required for its participation in NF-kB activation (Holler et al., 2000; Jäättelä and Tschopp, 2003).”
BackgroundEmbryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., & Baltimore, D. (1995) · Nature · doi:10.1038/376167a0 · Cited by 1,825 · cited 2×
“A similar mechanism might mediate the protective action of NF-kB in the fetal liver (Beg et al., 1995, Kucharczak et al., 2003).”
BackgroundKamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Hentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., & Davis, R. J. (2000) · Science · doi:10.1126/science.288.5467.870 · Cited by 1,728 · cited 1×
“…jnk1 and jnk2 in mouse embryonic fibroblasts (MEFs) prevents mitochondrial release of cytochrome c and apoptosis elicited by various stress stimuli (Tournier et al., 2000), and thymocytes and peripheral T cells from jnk1 / or jnk2 / mice are refractory to anti-CD3induced PCD and activation-induced…”
BackgroundFour deaths and a funeral: from caspases to alternative mechanisms
Leist, M., & Jäättelä, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085008 · Cited by 1,587 · cited 8×
“Other studies confirmed a role for JNK and ROS in TNFa-induced necrosis (Leist and Jäättelä, 2001; Jäättelä and Tschopp, 2003; Sakon et al., 2003; Kamata et al., 2005).”
BackgroundInfluentialDithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508 · cited 2×
“Further, most NF-kB-activating agents were initially found to induce the formation of ROS (Schreck et al., 1992a; Schmidt et al., 1995; Bowie and O’Neill, 2000; Gloire et al., 2006), and frank exposure to H2O2 or other oxidants was shown to trigger nuclear translocation of NF-kB in certain cells…”
BackgroundSchreck, R., Albermann, K., & Baeuerle, P. A. (1992) · Free Radical Research Communications · doi:10.3109/10715769209079515 · Cited by 1,401 · cited 2×
“Further, most NF-kB-activating agents were initially found to induce the formation of ROS (Schreck et al., 1992a; Schmidt et al., 1995; Bowie and O’Neill, 2000; Gloire et al., 2006), and frank exposure to H2O2 or other oxidants was shown to trigger nuclear translocation of NF-kB in certain cells…”
BackgroundThe IKK NF-κB system: a treasure trove for drug development
Karin, M., Yamamoto, Y., & Wang, Q. M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1279 · Cited by 1,364 · cited 8×
“…of target genes (Papa et al., 2006), this therapeutic approach might also enable dissociation of prosurvival and immune functions of NF-kB, and thus, minimize side effects associated with standard NF-kB inhibitors, such as immunosuppressive effects (Kucharczak et al., 2003; Karin et al., 2004).”
BackgroundInfluentialDeath by design: apoptosis, necrosis and autophagy
Edinger, A. L., & Thompson, C. B. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.011 · Cited by 1,364 · cited 6×
“…consequence of making this choice, however, at least in vivo, is that whereas necrotic cells are a trigger for inflammation, apoptotic cells are potent suppressors of both immune and inflammatory responses (Jäättelä and Tschopp, 2003; Edinger and Thompson, 2004).”
BackgroundInfluentialAbsence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
Yang, D. D., Kuan, C.-Y., Whitmarsh, A. J., Rinócn, M., Zheng, T. S., Davis, R. J., Rakic, P., & Flavell, R. A. (1997) · Nature · doi:10.1038/39899 · Cited by 1,238 · cited 2×
“In neurons, for instance, excitotoxin-inflicted apoptosis depends on JNK3mediated phosphorylation of the transcription factor, c-Jun, and consequent modulation of gene expression by this factor (Yang et al., 1997; Davis, 2000; Karin and Oncogene Gallagher, 2005).”
BackgroundGiorgio, M., Migliaccio, E., Orsini, F., Paolucci, D., Moroni, M., Contursi, C., Pelliccia, G., Luzi, L., Minucci, S., Marcaccio, M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.011 · Cited by 1,176 · cited 1×
“Indeed, many death-inducing stimuli were recently shown to have the ability to activate the signaling molecule, p66Shc, which upon activation prompts the production of ROS in mitochondria, causing oxidation of cytochrome c and ultimately cell death (Giorgio et al., 2005).”
BackgroundRegulation of ferritin genes and protein
Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173 · cited 10×
“…of FHC extends to genotoxic and oxidative stress (Arosio and Levi, 2002; Torti and Torti, 2002), and in certain human tumors, high FHC levels have been associated with anaplasia, metastatic spread and poor prognosis (Torti and Torti, 2002; Hentze et al., 2004; reviewed in Papa et al., 2006).”
BackgroundInfluentialMaeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Reactive Oxygen Species as Intracellular Messengers During Cell Growth and Differentiation
Sauer, H., Wartenberg, M., & Hescheler, J. (2001) · Cellular Physiology and Biochemistry · doi:10.1159/000047804 · Cited by 1,118 · cited 2×
“ROS are, in fact, implicated as second messengers in an array of biological responses (Thannickal and Fanburg, 2000; Sauer et al., 2001; Curtin et al., 2002; Martindale and Holbrook, 2002; Balaban et al., 2005); most often, however, an elevation of their activity is associated with the induction of…”
BackgroundNuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933 · cited 9×
“…and pathogenesis of widespread human diseases, ranging from cancer and chronic inflammation to vascular and metabolic disorders (Kucharczak et al., 2003; Greten and Karin, 2004; Kumar et al., 2004; Bottero et al., 2006; Courtois and Smahi, 2006; Karin, 2006; Kim et al., 2006; Papa et al., 2006).”
BackgroundInfluentialMore than one way to die: apoptosis, necrosis and reactive oxygen damage
Fiers, W., Beyaert, R., Declercq, W., & Vandenabeele, P. (1999) · Oncogene · doi:10.1038/sj.onc.1203249 · Cited by 864 · cited 1×
“…it is plausible that both qualitative and quantitative aspects of ROS and JNK activities, such as intensity and duration, also play an important role in determining the biological outcome of TNF-R stimulation with regard to cell fate (Fiers et al., 1999; Nakano et al., 2006; Papa et al., 2006).”
BackgroundRedox Regulation of NF-kappa B Activation
Flohé, L., Brigelius-Flohé, R., Saliou, C., Traber, M. G., & Packer, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00501-1 · Cited by 859 · cited 2×
“Soon after the initial discovery of NF-kB, several studies implicated ROS as central effectors for activation of this factor by an array of triggers (Schreck et al., 1991; reviewed in Baeuerle and Henkel, 1994; Flohe et al., 1997; Gloire et al., 2006).”
BackgroundOxidative stress and nuclear factor-κB activation
Bowie, A., & O’Neill, L. A. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00296-8 · Cited by 858
Matthews, J. R., Wakasugi, N., virelizier, J.-L., Yodoi, J., & Hay, R. T. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.15.3821 · Cited by 831 · cited 13×
“…effects of ROS are primarily mediated through oxidation of a conserved, redox-sensitive cysteine residue, Cys-62, located in a region of the RHD of p50 that directly contacts DNA (Matthews et al., 1992; Haddad, 2002; Michiels et al., 2002; Nishi et al., 2002; Brigelius-Flohe et al., 2004).”
BackgroundMethodInfluentialIs NF-kappaB the sensor of oxidative stress?
Li, N., & Karin, M. (1999) · PubMed · Cited by 786
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 769
Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling
De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R., & Franzoso, G. (2001) · Nature · doi:10.1038/35104560 · Cited by 732 · cited 7×
“Yet, in some NF-kB null systems, TNF-R-elicited JNK and ROS activities have primarily been implicated in induction of apoptosis (De Smaele et al., 2001; Tang et al., 2001; Pham et al., 2004).”
BackgroundInfluentialSelf-citationInhibition of JNK activation through NF-κB target genes
Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., & Lin, A. (2001) · Nature · doi:10.1038/35104568 · Cited by 721 · cited 7×
“Yet, in some NF-kB null systems, TNF-R-elicited JNK and ROS activities have primarily been implicated in induction of apoptosis (De Smaele et al., 2001; Tang et al., 2001; Pham et al., 2004).”
BackgroundInfluentialTraenckner, E. B., Wilk, S., & Baeuerle, P. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06878.x · Cited by 710 · cited 1×
“…triggered by cytokines, microbial products or ionizing radiation, suggesting that the ROS-sensitive step in the NF-kB activation pathways induced by these stimuli lies either at the level or upstream of the IKK complex (Traenckner et al., 1994; Kretz-Remy et al., 1996; Gloire et al., 2006).”
BackgroundChang, L., Kamata, H., Solinas, G., Luo, J.-L., Maeda, S., Venuprasad, K., Liu, Y.-C., & Karin, M. (2006) · Cell · doi:10.1016/j.cell.2006.01.021 · Cited by 706 · cited 2×
“…JNK-mediated toxicity, Itch / mice are refractory to TNFa-induced liver failure in various models of hepatic challenge, and cells from either these or jnk1 / mice exhibit defective ubiquitinmediated proteolysis of c-FLIPL during these challenges (Chang et al., 2006; Schwabe and Brenner, 2006).”
BackgroundIs NF‐κB the sensor of oxidative stress?
Li, N., & Karin, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1137 · Cited by 701 · cited 19×
“Oncogene with this notion, suppression of NF-kB activity by either knockout of rela or ikkb or by overexpression of the IkBa super-repressor (a hyperactive variant of the natural inhibitor IkBa) markedly impairs normal downregulation of TNFa-elicited JNK signaling (De Smaele et al., 2001; Tang et al., 2001; Papa et al…”
BackgroundResultInfluentialMechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways
Schwabe, R. F., & Brenner, D. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00422.2005 · Cited by 685
Perkins, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209937 · Cited by 674 · cited 1×
“…transcription factors and their role in control of PCD are the subject of other articles in this issue (Dutta et al., 2006; Gilmore, 2006; Perkins, 2006; Scheidereit, 2006) and of excellent reviews previously published elsewhere (Gerondakis and Strasser, 2003; Kucharczak et al., 2003;…”
BackgroundNuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Bassères, D. S., & Baldwin, A. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209942 · Cited by 667
Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb
Janssen-Heininger, Y. M. W., Poynter, M. E., & Baeuerle, P. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00218-5 · Cited by 666
Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.10.017 · Cited by 663
Self-citationTyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α
Imbert, V., Rupec, R. A., Livolsi, A., Pahl, H. L., Traenckner, E. B.-M., Mueller-Dieckmann, C., Farahifar, D., Rossi, B., Auberger, P., Baeuerle, P. A., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80153-1 · Cited by 660
Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro.
Toledano, M. B., & Leonard, W. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4328 · Cited by 657 · cited 1×
“…a reduced state in order to bind to DNA, as shown by the observations that reducing agents such as dithiothreitol and mercaptoethanol can enhance NF-kB DNA binding, whereas oxidizing agents such as diamides can inhibit it (Molitor et al., 1991; Toledano and Leonard, 1991; Bowie and O’Neill, 2000).”
BackgroundIκB kinase complexes: gateways to NF-κB activation and transcription
Scheidereit, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209934 · Cited by 651 · cited 18×
“Oncogene with this notion, suppression of NF-kB activity by either knockout of rela or ikkb or by overexpression of the IkBa super-repressor (a hyperactive variant of the natural inhibitor IkBa) markedly impairs normal downregulation of TNFa-elicited JNK signaling (De Smaele et al., 2001; Tang et al., 2001; Papa et al…”
BackgroundInfluentialDistinct Roles of Thioredoxin in the Cytoplasm and in the Nucleus
Hirota, K., Murata, M., Sachi, Y., Nakamura, H., Takeuchi, J., Mori, K., & Yodoi, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27891 · Cited by 611 · cited 9×
“…and Holbrook, 2002; Kabe et al., 2005); whereas in the nucleus, DNA binding and transcriptional activity of NF-kB dimers require the presence of a reducing environment, created in part through the action of Trx (Hirota et al., 1999; Haddad, 2002; Martindale and Holbrook, 2002; Kabe et al., 2005).”
BackgroundInfluentialRicci, J.-E., Muñoz-Pinedo, C., Fitzgerald, P., Bailly-Maitre, B., Perkins, G. A., Yadava, N., Scheffler, I. E., Ellisman, M. H., & Green, D. R. (2004) · Cell · doi:10.1016/j.cell.2004.05.008 · Cited by 602 · cited 1×
“Indeed, executioner caspase-3 can induce the production of ROS in mitochondria by cleaving components of complex I of the electron transport chain (Ricci et al., 2004).”
BackgroundROS, stress‐activated kinases and stress signaling in cancer
Benhar, M., Engelberg, D., & Levitzki, A. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf094 · Cited by 600 · cited 4×
“Accumulating evidence suggest that FHC also plays an important role in mediating some of the critical functions of NF-kB in cancer (Benhar et al., 2002; Torti and Torti, 2002).”
BackgroundInfluentialRoles for NF-κB in nerve cell survival, plasticity, and disease
Mattson, M. P., & Meffert, M. K. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401837 · Cited by 595 · cited 3×
“…may play a significant pathogenetic role, such as other inflammatory diseases, sepsis, ischemia/reperfusion injury, and cardiovascular and neuro-degenerative diseases, including Parkinson’s and Alzheimer’s diseases (Haddad, 2002; Kumar et al., 2004; Victor et al., 2004; Mattson and Meffert, 2006).”
BackgroundKabe, Y., Ando, K., Hirao, S., Yoshida, M., & Handa, H. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.395 · Cited by 585
Regulation and measurement of oxidative stress in apoptosis
Curtin, J. F., Donovan, M., & Cotter, T. G. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00070-4 · Cited by 584 · cited 16×
“In eukaryotes, iron is involved in both production of mitochondrial O2 and Fenton and Haber-Weiss reactions, generating highly reactive OH radicals (Arosio and Levi, 2002; Curtin et al., 2002; Torti and Torti, 2002).”
BackgroundInfluentialInhibitors of NF-κB signaling: 785 and counting
Gilmore, T. D., & Herscovitch, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209982 · Cited by 569 · cited 1×
“…are also being increasingly used in patients with certain malignancies such as multiple myeloma, Hodgkin’s lymphoma (HL), non-HL and certain solid tumors (Kucharczak et al., 2003; Greten and Karin, 2004; Karin et al., 2004; Kim et al., 2006; Papa et al., 2006; see Gilmore and Herscovitch, 2006).”
BackgroundMattson, M. P., Goodman, Y., Luo, H., Fu, W., & Furukawa, K. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970915)49:6<681::aid-jnr3>3.0.co;2-3 · Cited by 567 · cited 1×
“Indeed, some studies support a role for the antioxidant function of NF-kB in cytoprotection against arsenic- and oxidative stress-induced killing (Mattson et al., 1997; Chen et al., 2003; Zhang and Chen, 2004; Nakano et al., 2006).”
BackgroundManna, S. K., Zhang, H. J., Yan, T., Oberley, L. W., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13245 · Cited by 564 · cited 5×
“…these inhibitory effects of antioxidant compounds and overexpressed peroxidases on IkBa degradation induced by various stimuli, including TNFa, PMA and LPS (Manna et al., 1998; Li and Karin, 1999; Gloire et al., 2006), which would explain the broad spectrum of activity of certain ROS scavengers.”
BackgroundInfluentialA JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis
Deng, Y., Ren, X., Yang, L., Lin, Y., & Wu, X. (2003) · Cell · doi:10.1016/s0092-8674(03)00757-8 · Cited by 559 · cited 4×
“…activation by various means – including knockout of jnk genes and silencing of the JNK kinase MKK7 – virtually abrogates TNFa-inflicted cytotoxicity in NF-kB-deficient cells (De Smaele et al., 2001; Tang et al., 2001; Deng et al., 2003; Ventura et al., 2004; Kamata et al., 2005; Papa et al., 2006).”
BackgroundInfluentialDual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways
Vercammen, D., Brouckaert, G., Denecker, G., Van de Craen, M., Declercq, W., Fiers, W., & Vandenabeele, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.919 · Cited by 556 · cited 2×
“Thus, ROS accumulation induced downstream of DRs seemingly involves both caspase-dependent and caspase-independent mechanisms (Vercammen et al., 1998; Holler et al., 2000; Cauwels et al., 2003; Vanden Berghe et al., 2003).”
BackgroundNF-κB as a therapeutic target in cancer
Orlowski, R. Z., & Baldwin, A. S. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02375-4 · Cited by 553 · cited 1×
“…of NF-kB has been associated with promotion of cell viability during oncogenic transformation, survival of late-stage tumors (Gilmore, 2003) and resistance of cancer cells to anticancer therapy (Orlowski and Baldwin, 2002; Kucharczak et al., 2003; Greten and Karin, 2004; Kim et al., 2006).”
BackgroundArosio, P., & Levi, S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00842-0 · Cited by 542 · cited 3×
“In eukaryotes, iron is involved in both production of mitochondrial O2 and Fenton and Haber-Weiss reactions, generating highly reactive OH radicals (Arosio and Levi, 2002; Curtin et al., 2002; Torti and Torti, 2002).”
BackgroundSakon, S., Xue, X., Takekawa, M., Sasazuki, T., Okazaki, T., Kojima, Y., Piao, J., Yagita, H., Okumura, K., Doi, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg379 · Cited by 497 · cited 22×
“Notably, the acute phase of this activation is instead virtually unaffected by these agents (Sakon et al., 2003; Pham et al., 2004; Kamata et al., 2005), indicating that the elevation of ROS and sustained (but not acute) JNK activity are part of the same deathinducing mechanism elicited by TNF-Rs…”
BackgroundInfluentialGood cop, bad cop: the different faces of NF-κB
Perkins, N. D., & Gilmore, T. D. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401838 · Cited by 489 · cited 4×
“Indeed, whereas being usually a signal for survival, NF-kB activity in certain circumstances can promote PCD (Kucharczak et al., 2003; Karin, 2006; Papa et al., 2006; Perkins and Gilmore, 2006; see Dutta et al., 2006).”
BackgroundInfluentialHayashi, T., Ueno, Y., & Okamoto, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82135-4 · Cited by 487
Compartmentalization of TNF Receptor 1 Signaling
Schneider-Brachert, W., Tchikov, V., Neumeyer, J., Jakob, M., Winoto-Morbach, S., Held-Feindt, J., Heinrich, M., Merkel, O., Ehrenschwender, M., Adam, D., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.017 · Cited by 485 · cited 2×
“This complex then leads to activation of NF-kB, which sustains cell survival (Micheau and Tschopp, 2003; Wajant et al., 2003; Schneider-Brachert et al., 2004; Papa et al., 2006).”
BackgroundAntioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors
Haddad, J. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00053-0 · Cited by 427 · cited 13×
“…effects of ROS are primarily mediated through oxidation of a conserved, redox-sensitive cysteine residue, Cys-62, located in a region of the RHD of p50 that directly contacts DNA (Matthews et al., 1992; Haddad, 2002; Michiels et al., 2002; Nishi et al., 2002; Brigelius-Flohe et al., 2004).”
BackgroundMethodInfluentialNitrosation and oxidation in the regulation of gene expression
Marshall, H. E., Merchant, K., & Stamler, J. S. (2000) · The FASEB Journal · doi:10.1096/fj.00.011rev · Cited by 424 · cited 1×
“…ROS-mediated inhibition of NF-kB activity Accumulating evidence suggests that, although in limited doses, endogenous ROS may play an activating role in NF-kB signaling; above a certain threshold, they may actually negatively impact upon this signaling (Marshall et al., 2000; Michiels et al., 2002).”
BackgroundFrom JNK to Pay Dirt: Jun Kinases, their Biochemistry, Physiology and Clinical Importance
Karin, M., & Gallagher, E. (2005) · IUBMB Life · doi:10.1080/15216540500097111 · Cited by 412 · cited 9×
“…and the extracellular-regulated kinase (ERK) pathways, the JNK pathway transduces signals initiated by an array of stimuli via sequential phosphorylation of distinct kinase modules, ultimately eliciting an appropriate biological response to these stimuli (Davis, 2000; Karin and Gallagher, 2005).”
BackgroundInfluentialRegulatory Role for a Novel Human Thioredoxin Peroxidase in NF-κB Activation
Jin, D.-Y., Chae, H. Z., Rhee, S. G., & Jeang, K.-T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30952 · Cited by 412 · cited 8×
“An alternative hypothesis is that upstream, IKKactivating signaling molecules, such as NF-kB-Inducing Kinase (NIK), may be maintained in a non-functional state by an ROS-inhibitable regulator such as Trx (Jin et al., 1997; Bowie and O’Neill, 2000; JanssenHeininger et al., 2000; Schoonbroodt and Piette, 2000; Gloire et…”
BackgroundInfluentialThe IKK/NF-κB activation pathway—a target for prevention and treatment of cancer
Greten, F. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.08.029 · Cited by 410 · cited 6×
“…and pathogenesis of widespread human diseases, ranging from cancer and chronic inflammation to vascular and metabolic disorders (Kucharczak et al., 2003; Greten and Karin, 2004; Kumar et al., 2004; Bottero et al., 2006; Courtois and Smahi, 2006; Karin, 2006; Kim et al., 2006; Papa et al., 2006).”
BackgroundInfluentialCurrent insights into the regulation of programmed cell death by NF-κB
Dutta, J., Fan, Y., Gupta, N., Fan, G., & Gélinas, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209938 · Cited by 407 · cited 3×
“…including various cancers – where it promotes transformation, tumor progression and resistance to anticancer therapy (Brasseres and Baldwin, 2006; Dutta et al., 2006; see also Kucharczak et al., 2003; Karin, 2006; Kim et al., 2006) – chronic inflammatory diseases such as rheumatoid arthritis…”
BackgroundNF-κB and IKK as therapeutic targets in cancer
Kim, H. J., Hawke, N., & Baldwin, A. S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401877 · Cited by 391 · cited 9×
“…and pathogenesis of widespread human diseases, ranging from cancer and chronic inflammation to vascular and metabolic disorders (Kucharczak et al., 2003; Greten and Karin, 2004; Kumar et al., 2004; Bottero et al., 2006; Courtois and Smahi, 2006; Karin, 2006; Kim et al., 2006; Papa et al., 2006).”
BackgroundInfluentialEvidence that reactive oxygen species do not mediate NF- B activation
Hayakawa, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg332 · Cited by 381 · cited 4×
“…is refractory to the suppressive effects of NAC, PDTC and other antioxidants in various tissues (Moynagh et al., 1994; Brennan and O’Neill, 1995; Bonizzi et al., 1996; Bowie et al., 1997; Shrivastava and Aggarwal, 1999; Bowie and O’Neill, 2000; Garg and Aggarwal, 2002; Hayakawa et al., 2003).”
BackgroundInfluentialCaspase-independent cell death in T lymphocytes
Jäättelä, M., & Tschopp, J. (2003) · Nature Immunology · doi:10.1038/ni0503-416 · Cited by 367 · cited 17×
“…indications that mitochondrial factors such as apoptosis-inducing factor, the serine protease Omi, and lysosomal proteases of the cathepsin group (Jäättelä and Tschopp, 2003; SchneiderBrachert et al., 2004), as well as ROS may be important participants in the necrosis pathway elicited by…”
BackgroundInfluentialReactive oxygen species mediate crosstalk between NF-κB and JNK
Nakano, H., Nakajima, A., Sakon-Komazawa, S., Piao, J.-H., Xue, X., & Okumura, K. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401830 · Cited by 366 · cited 14×
“The relevance of each of these effectors to the NF-kBmediated antagonism of JNK signaling and PCD, however, is likely to differ depending upon specific cell type and biological context (Kucharczak et al., 2003; Nakano et al., 2006; Papa et al., 2006).”
BackgroundInfluentialKapahi, P., Takahashi, T., Natoli, G., Adams, S. R., Chen, Y., Tsien, R. Y., & Karin, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007204200 · Cited by 359 · cited 1×
“This residue is oxidized, for instance, upon treatment with arsenite (Kapahi et al., 2000), and this oxidation has been implicated in ROS-mediated inactivation of IKKb function in alveolar epithelial cells (Korn et al., 2001; Gloire et al., 2006).”
BackgroundGadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2
Papa, S., Zazzeroni, F., Bubici, C., Jayawardena, S., Alvarez, K., Matsuda, S., Nguyen, D. U., Pham, C. G., Nelsbach, A. H., Melis, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1093 · Cited by 321 · cited 3×
“Drugs that impede, for instance, Gadd45b binding to MKK7, FHC-mediated sequestration of iron or activity of MKPs might indeed succeed in producing these desirable outcomes.”
BackgroundSelf-citationImmune cells: free radicals and antioxidants in sepsis
Victor, V. M., Rocha, M., & De la Fuente, M. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.01.020 · Cited by 310 · cited 8×
“…therapeutic agents that selectively interfere with the restraint of this signaling by NF-kB are likely to enhance PCD preferentially in immune and inflammatory cells at sites of inflammation where there are high levels of TNFa and JNK and ROS activities (Kumar et al., 2004; Victor et al., 2004).”
BackgroundInfluentialAbsence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality
Doi, T. S., Marino, M. W., Takahashi, T., Yoshida, T., Sakakura, T., Old, L. J., & Obata, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2994 · Cited by 306 · cited 17×
“Notably, it was later shown that both liver damage and embryonic lethality in rela / mice can be reversed by compound ablation of TNF-R1 (Doi et al., 1999; Alcamo et al., 2001).”
BackgroundInfluentialVentura, J.-J., Cogswell, P., Flavell, R. A., Baldwin, A. S., & Davis, R. J. (2004) · Genes & Development · doi:10.1101/gad.1223004 · Cited by 303 · cited 33×
“Other studies confirmed a role for JNK and ROS in TNFa-induced necrosis (Leist and Jäättelä, 2001; Jäättelä and Tschopp, 2003; Sakon et al., 2003; Kamata et al., 2005).”
BackgroundInfluentialIKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα
Maeda, S., Chang, L., Li, Z.-W., Luo, J.-L., Leffert, H., & Karin, M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00301-7 · Cited by 286 · cited 3×
“Conditional knockout of ikkb in hepatocytes leads to sustained activation of JNK signaling following challenge with ConA, and inhibition of this signaling by ablation of either jnk1 or jnk2 markedly attenuates ConA-elicited injury in NF-kB-deficient livers (Maeda et al., 2003).”
BackgroundInfluentialKretz-Remy, C., Mehlen, P., Mirault, M. E., & Arrigo, A. P. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.5.1083 · Cited by 283 · cited 1×
“…triggered by cytokines, microbial products or ionizing radiation, suggesting that the ROS-sensitive step in the NF-kB activation pathways induced by these stimuli lies either at the level or upstream of the IKK complex (Traenckner et al., 1994; Kretz-Remy et al., 1996; Gloire et al., 2006).”
BackgroundStress-Responsive Protein Kinases in Redox-Regulated Apoptosis Signaling
Matsuzawa, A., & Ichijo, H. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.472 · Cited by 282 · cited 27×
“Notably, it was later shown that both liver damage and embryonic lethality in rela / mice can be reversed by compound ablation of TNF-R1 (Doi et al., 1999; Alcamo et al., 2001).”
BackgroundInfluentialInvolvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation
Béraud, C., Henzel, W. J., & Baeuerle, P. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.429 · Cited by 281 · cited 4×
“…of IkBa has been shown to involve phosphatidylinositol 3-kinase (PI3K) (Beraud et al., 1999), which can stably interact with Tyr-42-phosphorylated IkBa through the PI3K regulatory subunit p85 (Beraud et al., 1999) and PTKs such as caseine kinase II (Haddad, 2002; Gloire et al., 2006).”
BackgroundInfluentialLee, C., Lee, S. M., Mukhopadhyay, P., Kim, S. J., Lee, S. C., Ahn, W.-S., Yu, M.-H., Storz, G., & Ryu, S. E. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb856 · Cited by 281 · cited 1×
“…activation of NF-kB signaling In bacteria and yeast, it is clear that oxidative stress directly controls the redox state of specific cysteine residues that control the activity of transcription factors that regulate genes for the antioxidant response (Lee et al., 2004; Wood et al., 2004).”
BackgroundNobel, C. S. I., Kimland, M., Lind, B., Orrenius, S., & Slater, A. F. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26202 · Cited by 280 · cited 1×
“In either system, PDTC exhibited prooxidant (rather than antioxidant) activity and it was by means of this activity that it blocked activation of NF-kB (Nobel et al., 1995; Brennan and O’Neill, 1996; Bowie and O’Neill, 2000).”
BackgroundSchoonbroodt, S., Ferreira, V., Best-Belpomme, M., Boelaert, J. R., Legrand-Poels, S., Korner, M., & Piette, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4292 · Cited by 263 · cited 15×
“Oncogene with this notion, suppression of NF-kB activity by either knockout of rela or ikkb or by overexpression of the IkBa super-repressor (a hyperactive variant of the natural inhibitor IkBa) markedly impairs normal downregulation of TNFa-elicited JNK signaling (De Smaele et al., 2001; Tang et al., 2001; Papa et al…”
BackgroundInfluentialJunD Mediates Survival Signaling by the JNK Signal Transduction Pathway
Lamb, J. A., Ventura, J.-J., Hess, P., Flavell, R. A., & Davis, R. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00203-x · Cited by 262 · cited 4×
“Additionally, functional interaction between the NF-kB and JNK pathways can occur at the transcriptional level, as the promoters of several genes controlling inflammation, PCD and tumorigenesis are jointly regulated by NF-kB and JNK-controlled transcription factors such as AP1 (Lamb et al., 2003; Zhang and Chen, 2004;…”
BackgroundInfluentialAlcamo, E., Mizgerd, J. P., Horwitz, B. H., Bronson, R., Beg, A. A., Scott, M., Doerschuk, C. M., Hynes, R. O., & Baltimore, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1592 · Cited by 259 · cited 1×
“Notably, it was later shown that both liver damage and embryonic lethality in rela / mice can be reversed by compound ablation of TNF-R1 (Doi et al., 1999; Alcamo et al., 2001).”
BackgroundCross-talk between nuclear receptors and nuclear factor κB
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209935 · Cited by 247 · cited 1×
“…human diseases, such as cardiovascular and chronic inflammatory diseases, is underscored by the widespread use of NF-kBtargeting agents (e.g., NSAIDs and glucocorticoids) for treatment of these diseases Kucharczak et al., 2003; Karin et al., 2004; Kumar et al., 2004; see De Bosscher et al., 2006).”
BackgroundOxidative stress interference with the nuclear factor- κB activation pathways
Schoonbroodt, S., & Piette, J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00371-3 · Cited by 240 · cited 12×
“…of NF-kB by an array of stimuli, including TNFa, IL-1b, phorbol 12-myristate 13-acetate (PMA), lipopolysaccharide (LPS), doublestranded (ds)RNA, cycloheximide and H2O2, in a wide range of cell types (Schreck et al., 1991; Bowie and O’Neill, 2000; Schoonbroodt and Piette, 2000; Gloire et al., 2006).”
BackgroundInfluentialPapa, S., Bubici, C., Zazzeroni, F., Pham, C. G., Kuntzen, C., Knabb, J. R., Dean, K., & Franzoso, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401865 · Cited by 235 · cited 62×
“Other studies confirmed a role for JNK and ROS in TNFa-induced necrosis (Leist and Jäättelä, 2001; Jäättelä and Tschopp, 2003; Sakon et al., 2003; Kamata et al., 2005).”
BackgroundInfluentialSelf-citationAoki, M., Nata, T., Morishita, R., Matsushita, H., Nakagami, H., Yamamoto, K., Yamazaki, K., Nakabayashi, M., Ogihara, T., & Kaneda, Y. (2001) · Hypertension · doi:10.1161/01.hyp.38.1.48 · Cited by 232 · cited 1×
“This deathinducing role for NF-kB was reported, for instance, during oxidative injury in some systems (Luo et al., 1999; Vollgraf et al., 1999; Shou et al., 2000; Aoki et al., 2001).”
BackgroundReactive oxygen intermediates in TNF signaling
Garg, A. K., & Aggarwal, B. B. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00207-9 · Cited by 228 · cited 4×
“…is refractory to the suppressive effects of NAC, PDTC and other antioxidants in various tissues (Moynagh et al., 1994; Brennan and O’Neill, 1995; Bonizzi et al., 1996; Bowie et al., 1997; Shrivastava and Aggarwal, 1999; Bowie and O’Neill, 2000; Garg and Aggarwal, 2002; Hayakawa et al., 2003).”
BackgroundInfluentialSpatial Redox Regulation of a Critical Cysteine Residue of NF-κB in Vivo
Nishi, T., Shimizu, N., Hiramoto, M., Sato, I., Yamaguchi, Y., Hasegawa, M., Aizawa, S., Tanaka, H., Kataoka, K., Watanabe, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202970200 · Cited by 226 · cited 1×
“…effects of ROS are primarily mediated through oxidation of a conserved, redox-sensitive cysteine residue, Cys-62, located in a region of the RHD of p50 that directly contacts DNA (Matthews et al., 1992; Haddad, 2002; Michiels et al., 2002; Nishi et al., 2002; Brigelius-Flohe et al., 2004).”
BackgroundQin, J., Clore, G. M., Kennedy, W. P., Huth, J. R., & Gronenborn, A. M. (1995) · Structure · doi:10.1016/s0969-2126(01)00159-9 · Cited by 225 · cited 1×
“Interestingly, Trx was found to form a stable interaction with the aforementioned DNA-binding loop of p50 (Qin et al., 1995), prompting reduction Cys-62 in a specific manner (Hayashi et al., 1993; Jin et al., 1997; Hirota et al., 2001; Haddad, 2002).”
BackgroundBonizzi, G., Piette, J., Schoonbroodt, S., Greimers, R., Havard, L., Merville, M.-P., & Bours, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1950 · Cited by 219 · cited 4×
“…noting that the ROS involved in activation of NF-kB downstream of IL-1bR in lymphoid and monocytic cells have been proposed to be produced by different enzymatic systems, namely by the 5-LOX and NADPH oxidase systems, respectively (Bonizzi et al., 1999; Bonizzi et al., 2000; Gloire et al., 2006).”
BackgroundInfluentialCauwels, A., Janssen, B., Waeytens, A., Cuvelier, C., & Brouckaert, P. (2003) · Nature Immunology · doi:10.1038/ni914 · Cited by 217 · cited 1×
“Thus, ROS accumulation induced downstream of DRs seemingly involves both caspase-dependent and caspase-independent mechanisms (Vercammen et al., 1998; Holler et al., 2000; Cauwels et al., 2003; Vanden Berghe et al., 2003).”
BackgroundTPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105
Belich, M. P., Salmerón, A., Johnston, L. H., & Ley, S. C. (1999) · Nature · doi:10.1038/16946 · Cited by 213 · cited 1×
“Other routes of activation, however, such as that involving phosphorylation of the p50 precursor, p105, by the kinase Tpl2, followed by proteolytic processing, also exist (Belich et al., 1999).”
BackgroundObin, M., Shang, F., Gong, X., Handelman, G., Blumberg, J., & Taylor, A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.7.561 · Cited by 205 · cited 17×
“It was noted, for instance, that activation of NF-kB by exposure to H2O2 proceeds slowly (generally taking hours), whereas that by other stimuli such as cytokines is often detected within a few minutes – before any measurable elevation of ROS levels by these stimuli (Bonizzi et al., 1996; Li and Karin, 1999; Bowie and…”
BackgroundInfluentialGhoda, L., Lin, X., & Greene, W. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21281 · Cited by 204 · cited 1×
“Oxidants may also induce activity of pp90rsk (Abe et al., 2000), as well as NIK autophosphorylation, events that are both capable of promoting activation of NF-kB (Ghoda et al., 1997; Schoonbroodt and Piette, 2000; Zhang et al., 2001; Gloire et al., 2006).”
BackgroundBrennan, P., & O'Neill, L. A. J. (1995) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(94)00186-7 · Cited by 203
Regulation of gene expression by oxygen: NF-κB and HIF-1, two extremes
Michiels, C., Minet, E., Mottet, D., & Raes, M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01045-6 · Cited by 201 · cited 5×
“…effects of ROS are primarily mediated through oxidation of a conserved, redox-sensitive cysteine residue, Cys-62, located in a region of the RHD of p50 that directly contacts DNA (Matthews et al., 1992; Haddad, 2002; Michiels et al., 2002; Nishi et al., 2002; Brigelius-Flohe et al., 2004).”
BackgroundResultInfluentialKorn, S. H., Wouters, E. F. M., Vos, N., & Janssen-Heininger, Y. M. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104321200 · Cited by 200 · cited 1×
“This residue is oxidized, for instance, upon treatment with arsenite (Kapahi et al., 2000), and this oxidation has been implicated in ROS-mediated inactivation of IKKb function in alveolar epithelial cells (Korn et al., 2001; Gloire et al., 2006).”
BackgroundBowie, A. G., Moynagh, P. N., & O'Neill, L. A. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25941 · Cited by 187 · cited 4×
“Further, it was reported that not all inducers of NF-kB have the ability to also trigger ROS formation (Royall et al., 1992; O’Donnell et al., 1995; Bonizzi et al., 1996; Bowie et al., 1997; Bowie and O’Neill, 2000; Gloire et al., 2006).”
BackgroundInfluentialMultistep Carcinogenesis: A Chain Reaction of Aneuploidizations
Duesberg, P., & Li, R. (2003) · Cell Cycle · doi:10.4161/cc.2.3.382 · Cited by 187
Structural basis for redox regulation of Yap1 transcription factor localization
Wood, M. J., Storz, G., & Tjandra, N. (2004) · Nature · doi:10.1038/nature02790 · Cited by 175 · cited 1×
“…activation of NF-kB signaling In bacteria and yeast, it is clear that oxidative stress directly controls the redox state of specific cysteine residues that control the activity of transcription factors that regulate genes for the antioxidant response (Lee et al., 2004; Wood et al., 2004).”
BackgroundZhang, Y., & Chen, F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3361 · Cited by 175 · cited 9×
“The basis for the effects of NF-kB on cyp1b1 expression has yet to be determined (Zhang and Chen, 2004; Nakano et al., 2006).”
BackgroundInfluentialVollgraf, U., Wegner, M., & Richter‐Landsberg, C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732501.x · Cited by 172
Schmidt, K. N., Traenckner, E. B.-M., Meier, B., & Baeuerle, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27136 · Cited by 171 · cited 4×
“Overexpression of catalase, which disposes instead of H2O2, also produced confounding results, as catalase was shown to blunt TNFa-mediated induction of NF-kB in some cells (Schmidt et al., 1995), but not in others (Suzuki et al., 1995).”
BackgroundResultInfluentialDisruption of HSP90 Function Reverts Tumor Necrosis Factor-induced Necrosis to Apoptosis
Vanden Berghe, T., Kalai, M., van Loo, G., Declercq, W., & Vandenabeele, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208925200 · Cited by 165 · cited 1×
“Thus, ROS accumulation induced downstream of DRs seemingly involves both caspase-dependent and caspase-independent mechanisms (Vercammen et al., 1998; Holler et al., 2000; Cauwels et al., 2003; Vanden Berghe et al., 2003).”
BackgroundBonizzi, G., Piette, J., Merville, M.-P., & Bours, V. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00290-7 · Cited by 158 · cited 1×
“…noting that the ROS involved in activation of NF-kB downstream of IL-1bR in lymphoid and monocytic cells have been proposed to be produced by different enzymatic systems, namely by the 5-LOX and NADPH oxidase systems, respectively (Bonizzi et al., 1999; Bonizzi et al., 2000; Gloire et al., 2006).”
BackgroundO'Donnell, V. B., Spycher, S., & Azzi, A. (1995) · Biochemical Journal · doi:10.1042/bj3100133 · Cited by 155
Schieven, G. L., Mittler, R. S., Nadler, S. G., Kirihara, J. M., Bolen, J. B., Kanner, S. B., & Ledbetter, J. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32051-3 · Cited by 148
Storz, P. (2006) · Science's STKE · doi:10.1126/stke.3322006re3 · Cited by 143 · cited 8×
“Nevertheless, this formation is often assumed to occur in mitochondria (Jäättelä and Tschopp, 2003; Kamata et al., 2005; Nakano et al., 2006; Papa et al., 2006), which is the main source of ROS in eukaryotes (Curtin et al., 2002; Storz, 2006).”
BackgroundInfluentialNF-κB and the regulation of hematopoiesis
Bottero, V., Withoff, S., & Verma, I. M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401888 · Cited by 142 · cited 4×
“…and pathogenesis of widespread human diseases, ranging from cancer and chronic inflammation to vascular and metabolic disorders (Kucharczak et al., 2003; Greten and Karin, 2004; Kumar et al., 2004; Bottero et al., 2006; Courtois and Smahi, 2006; Karin, 2006; Kim et al., 2006; Papa et al., 2006).”
BackgroundInfluentialReactive Oxygen Species Activate p90 Ribosomal S6 Kinase via Fyn and Ras
Abe, J.-I., Okuda, M., Huang, Q., Yoshizumi, M., & Berk, B. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1739 · Cited by 141 · cited 1×
“Oxidants may also induce activity of pp90rsk (Abe et al., 2000), as well as NIK autophosphorylation, events that are both capable of promoting activation of NF-kB (Ghoda et al., 1997; Schoonbroodt and Piette, 2000; Zhang et al., 2001; Gloire et al., 2006).”
BackgroundBrennan, P., & O'Neill, L. A. J. (1996) · Biochemical Journal · doi:10.1042/bj3200975 · Cited by 134
Livolsi, A., Busuttil, V., Imbert, V., Abraham, R. T., & Peyron, J. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02028.x · Cited by 131 · cited 2×
“In certain cells, however, such as Jurkat T cells, Tyr-42 phosphorylation of IkBa appears to depend on p56Lck and ZAP-70 (Livolsi et al., 2001).”
BackgroundBeginnings of a signal-transduction pathway for bioenergetic control of cell survival
Hammerman, P. S., Fox, C. J., & Thompson, C. B. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.09.008 · Cited by 129 · cited 2×
“Finally, another element that is increasingly being recognized as critical in influencing the choice between induction of necrosis and apoptosis is the metabolic state of the cell (Hammerman et al., 2004; Edinger and Thompson, 2004).”
BackgroundRedox events in interleukin-1 signaling
Brigelius‐Flohé, R., Banning, A., Kny, M., & Böl, G. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.12.008 · Cited by 128 · cited 1×
“…effects of ROS are primarily mediated through oxidation of a conserved, redox-sensitive cysteine residue, Cys-62, located in a region of the RHD of p50 that directly contacts DNA (Matthews et al., 1992; Haddad, 2002; Michiels et al., 2002; Nishi et al., 2002; Brigelius-Flohe et al., 2004).”
BackgroundHydrogen Peroxide Activates NF κ B and the Interleukin-6 Promoter Through NF κ B-Inducing Kinase
Zhang, J., Johnston, G., Stebler, B., & Keller, E. T. (2001) · Antioxidants & Redox Signaling · doi:10.1089/15230860152409121 · Cited by 125 · cited 1×
“Oxidants may also induce activity of pp90rsk (Abe et al., 2000), as well as NIK autophosphorylation, events that are both capable of promoting activation of NF-kB (Ghoda et al., 1997; Schoonbroodt and Piette, 2000; Zhang et al., 2001; Gloire et al., 2006).”
BackgroundDeciphering the pathway from the TCR to NF-κB
Weil, R., & Israël, A. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401856 · Cited by 125 · cited 1×
“…including maturation of B and T lymphocytes (Hayden and Ghosh, 2004; Bottero et al., 2006; Claudio et al., 2006), innate and adaptive immunity (Weil and Israël, 2006), bone morphogenesis epidermal homeostasis, hair follicle development, and neuronal development and function (Kucharczak et…”
BackgroundNF-κB-dependent MnSOD expression protects adenocarcinoma cells from TNF-α-induced apoptosis
Delhalle, S., Deregowski, V., Benoît, V., Merville, M., & Bours, V. (2002) · Oncogene · doi:10.1038/sj.onc.1205489 · Cited by 125 · cited 3×
“This might account for the inability of overexpressed Mn-SOD by itself to block TNFa-induced PCD in these cells (Delhalle et al., 2002; Sakon et al., 2003; Pham et al., 2004).”
BackgroundNF-κB RelA opposes epidermal proliferation driven by TNFR1 and JNK
Zhang, J. Y., Green, C. L., Tao, S., & Khavari, P. A. (2004) · Genes & Development · doi:10.1101/gad.1160904 · Cited by 124 · cited 2×
“…Kim et al., 2006), the NF-kB-mediated suppression of JNK signaling in epidermal keratinocytes was found to promote growth arrest, differentiation and tumor suppression – as proliferation and neoplastic outgrowth in this tissue are often reliant on JNK activity (Zhang et al., 2004; Karin, 2006).”
BackgroundLuo, Y., Hattori, A., Munoz, J. R., Qin, Z.-H., & Roth, G. S. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.254 · Cited by 120 · cited 1×
“This deathinducing role for NF-kB was reported, for instance, during oxidative injury in some systems (Luo et al., 1999; Vollgraf et al., 1999; Shou et al., 2000; Aoki et al., 2001).”
BackgroundMoynagh, P. N., Williams, D. C., & O'Neill, L. A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2681 · Cited by 105
NF-κB-related genetic diseases
Courtois, G., & Smahi, A. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401841 · Cited by 100
Jaspers, I., Zhang, W., Fraser, A., Samet, J. M., & Reed, W. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.6.4344 · Cited by 91 · cited 1×
“High levels of oxidized GSH were found to hinder activity of ubiquitinconjugating enzymes, and accordingly, block proteolysis of IkBa following treatment with H2O2 (Obin et al., 1998; Jaspers et al., 2001).”
BackgroundZAP-70-dependent and -independent Activation of Erk in Jurkat T Cells
Griffith, C. E., Zhang, W., & Wange, R. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10771 · Cited by 90 · cited 2×
“NF-kB has been implicated in upregulation of g-glutamyl-cysteine synthetase – the rate-limiting enzyme in GSH synthesis – by proinflammatory cytokines and other stimuli (Griffith et al., 1998; Victor et al., 2004).”
BackgroundSpiegelman, V. S., Stavropoulos, P., Latres, E., Pagano, M., Ronai, Z. A., Slaga, T. J., & Fuchs, S. Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100031200 · Cited by 75 · cited 1×
“…expression of molecules that trigger JNK activation such as TNFa, IL-1b and Fas ligand (Hayden and Ghosh, 2004; Zhang and Chen, 2004), JNK can upregulate expression of factors involved in activation of NF-kB by various stimuli such as the E3-ubiquitin ligase, b-TrCP (Spiegelman et al., 2001).”
BackgroundMukhopadhyay, A., Manna, S. K., & Aggarwal, B. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8549 · Cited by 74 · cited 1×
“Likewise, with pervanadate, IkBa degradation relies on the ubiquitin/proteasome system, rather than on calpains (Mukhopadhyay et al., 2000; Schoonbroodt and Piette, 2000; Gloire et al., 2006).”
BackgroundCyanide-Induced Apoptosis Involves Oxidative-Stress-Activated NF-κB in Cortical Neurons
Shou, Y., Gunasekar, P. G., Borowitz, J. L., & Isom, G. E. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.8900 · Cited by 71 · cited 1×
“This deathinducing role for NF-kB was reported, for instance, during oxidative injury in some systems (Luo et al., 1999; Vollgraf et al., 1999; Shou et al., 2000; Aoki et al., 2001).”
BackgroundThe role of Rel/NF-κB transcription factors in B lymphocyte survival
Gerondakis, S., & Strasser, A. (2003) · Seminars in Immunology · doi:10.1016/s1044-5323(03)00036-8 · Cited by 67 · cited 1×
“…in this issue (Dutta et al., 2006; Gilmore, 2006; Perkins, 2006; Scheidereit, 2006) and of excellent reviews previously published elsewhere (Gerondakis and Strasser, 2003; Kucharczak et al., 2003; Hayden and Ghosh, 2004; Bottero et al., 2006; Claudio et al., 2006; Courtois and Smahi, 2006;…”
BackgroundBonizzi, G., Dejardin, E., Piret, B., Piette, J., Merville, M., & Bours, V. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0544r.x · Cited by 67 · cited 5×
“…to H2O2 proceeds slowly (generally taking hours), whereas that by other stimuli such as cytokines is often detected within a few minutes – before any measurable elevation of ROS levels by these stimuli (Bonizzi et al., 1996; Li and Karin, 1999; Bowie and O’Neill, 2000; Gloire et al., 2006).”
BackgroundInfluentialShrivastava, A., & Aggarwal, B. B. (1999) · Antioxidants & Redox Signaling · doi:10.1089/ars.1999.1.2-181 · Cited by 65 · cited 2×
“…is refractory to the suppressive effects of NAC, PDTC and other antioxidants in various tissues (Moynagh et al., 1994; Brennan and O’Neill, 1995; Bonizzi et al., 1996; Bowie et al., 1997; Shrivastava and Aggarwal, 1999; Bowie and O’Neill, 2000; Garg and Aggarwal, 2002; Hayakawa et al., 2003).”
BackgroundBroad-spectrum caspase inhibition paradoxically augments cell death in TNF-α–stimulated neutrophils
Liu, C., Takemasa, A., Liles, W. C., Goodman, R. B., Jonas, M., Rosen, H., Chi, E. Y., Winn, R. K., Harlan, J. M., & Chuang, P. I. (2002) · Blood · doi:10.1182/blood-2001-12-0266 · Cited by 56 · cited 1×
“In fact, in some cases, Oncogene both this elevation and necrosis signaling are even enhanced by inhibition of caspases (Vercammen et al., 1998; Holler et al., 2000; Jäättelä and Tschopp, 2003; Liu et al., 2003; Papa et al., 2006).”
BackgroundSignaling from toxic metals to NF-kappaB and beyond: not just a matter of reactive oxygen species.
Chen, F., & Shi, X. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s5807 · Cited by 56 · cited 1×
“…and related kinases indicated that, in contrast to what was suggested in other reports (discussed above), oxidation of Cys-179 in either IKKa or IKKb would lead to the inhibition, rather than activation, of kinase activity (Chen and Shi, 2002; Michiels et al., 2002; Oncogene Gloire et al., 2006).”
ResultXie, C., Zhang, N., Zhou, H., Li, J., Li, Q., Zarubin, T., Lin, S.-C., & Han, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6673-6681.2005 · Cited by 52 · cited 6×
“The study showed that TNFa-induced sustained JNK signaling accelerates turnover of the caspase-8 antagonist, c-FLIPL, through a mechanism that involves activation of the E3 ubiquitin ligase, Itch, by direct JNK-mediated phosphorylation (Wajant et al., 2003; Chang et al., 2006; Karin, 2006).”
BackgroundInfluentialRoyall, J. A., Gwin, P. D., Parks, D. A., & Freeman, B. Α. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90742-f · Cited by 49 · cited 1×
“Further, it was reported that not all inducers of NF-kB have the ability to also trigger ROS formation (Royall et al., 1992; O’Donnell et al., 1995; Bonizzi et al., 1996; Bowie et al., 1997; Bowie and O’Neill, 2000; Gloire et al., 2006).”
BackgroundDeferoxamine reduces tissue injury and lethality in LPS-treated mice
Vulcano, M., Meiss, R. P., & Isturiz, M. A. (2000) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(00)00026-6 · Cited by 48 · cited 1×
“Remarkably, systemic administration of the iron chelator, DFO, protects mice against TNFR-mediated lethality and tissue injury (Vulcano et al., 2000).”
BackgroundJNK: a killer on a transcriptional leash
Franzoso, G., Zazzeroni, F., & Papa, S. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401154 · Cited by 47 · cited 1×
“Role of JNK in PCD signaling downstream of TNF-Rs Despite some initial doubts, the JNK cascade is now widely recognized as an essential player in PCD signaling downstream of TNF-Rs (Franzoso et al., 2003; Papa et al., 2006).”
BackgroundSelf-citationTransient Overexpression of Catalase Does Not Inhibit TNF- or PMA-Induced NF-κB Activation
Suzuki, Y., Mizuno, M., & Packer, L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1693 · Cited by 46 · cited 1×
“Overexpression of catalase, which disposes instead of H2O2, also produced confounding results, as catalase was shown to blunt TNFa-mediated induction of NF-kB in some cells (Schmidt et al., 1995), but not in others (Suzuki et al., 1995).”
ResultNF-κB guides the survival and differentiation of developing lymphocytes
Claudio, E., Brown, K. D., & Siebenlist, U. K. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401894 · Cited by 38 · cited 5×
“…of the TNF-R family such as BAFF-R and RANK – controlling B lymphopoiesis and osteoclastogenesis, respectively, through mechanisms that depend on NF-kB – as well as of DRs in this family, such as Fas (CD95) (Aggarwal, 2003; Kucharczak et al., 2003; Bottero et al., 2006; Claudio et al., 2006).”
BackgroundInfluentialSasazuki, T., Okazaki, T., Tada, K., Komazawa‐Sakon, S., Katano, M., Tanaka, M., Yagita∥, H., Okumura, K., Tominaga, N., Hayashizaki, Y., et al. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.030 · Cited by 31 · cited 1×
“Other antioxidant enzymes, such as metallothionein and glutathione S-transferase, have also recently been suggested to be under transcriptional control of NF-kB (Sasazuki et al., 2004).”
BackgroundAnti-Inflammatory Activities of Hypocretenolides from Leontodon hispidus
Zidorn, C., Dirsch, V. M., Rüngeler, P., Sosa, S., Loggia, R. D., Merfort, I., Pahl, H. L., Vollmar, A. M., & Stuppner, H. (1999) · Planta Medica · doi:10.1055/s-1999-14046 · Cited by 24
Hirota, K., Murata, M., Itoh, T., Yodoi, J., & Fukuda, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02094-4 · Cited by 14 · cited 1×
“Interestingly, Trx was found to form a stable interaction with the aforementioned DNA-binding loop of p50 (Qin et al., 1995), prompting reduction Cys-62 in a specific manner (Hayashi et al., 1993; Jin et al., 1997; Hirota et al., 2001; Haddad, 2002).”
Background
Research works printed but not linked: 1
- Gloire G, Legrand-Poels S, Piette J . (2006). Biochem Pharmacol, in press.
Cited by
Introduction to NF-κB: players, pathways, perspectives
Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209954 · Cited by 2,222
“…the dynamics and direct mechanisms of gene regulation by NF-kB (Hoffmann et al., 2006); post-translational modifications that regulate components of the NF-kB pathway (Perkins, 2006); and the controversial role of reactive oxygen species in the regulation of NF-kB activity (Bubici et al., 2006).”
BackgroundRedox regulation of cell survival
Trachootham, D., Lu, W., Ogasawara, M. A., Valle, N. R.-D., & Huang, P. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1957 · Cited by 1,781
“The integration of NF- B and JNK pathways in signaling apoptosis and cell survival in response to oxidative stress was recently reviewed (35, 224).”
The role of oxidative stress in neurodegenerative diseases
Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355
TNF-α signalling and inflammation: interactions between old acquaintances
Zelová, H., & Hošek, J. (2013) · Inflammation Research · doi:10.1007/s00011-013-0633-0 · Cited by 853
“But TNF-a uses ROS as secondary messengers to modulate the activity of NF-jB (for more information see the excellent reviews [89, 94]).”
BackgroundMolecular mechanisms of Nrf2‐mediated antioxidant response
Li, W., & Kong, A. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20465 · Cited by 785
“Persistent overload of reactive oxygen species (ROS) in chronic inflammation is also found correlated with an increased incidence of tumorigenesis [10-12].”
Background
Metadata
- Authors
- Bubici, C., Papa, S., Dean, K., & Franzoso, G.
- Affiliations
- University of Chicago (US)
- Corresponding author
- Franzoso, G
- Venue
- Oncogene
- Published
- 2006-10-30
- Volume
- 25
- Issue
- 51
- Pages
- 6731-6748
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2062711706
- Cited by
- 399
- References
- 149
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 11 · 2023: 15 · 2022: 14 · 2021: 15 · 2020: 18 · 2019: 9 · 2018: 10 · 2017: 11 · 2016: 16 · 2015: 21 · 2014: 25 · 2013: 32 · 2012: 37
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA098583, R01CA084040)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Keywords
- reactive oxygen species, nuclear factor-kappaB, c-Jun N-terminal kinase, MAPK signaling, programmed cell death, TNF-α, cell survival, inflammation, signal transduction, transcriptional regulation
- MeSH terms
- Animals, Humans, Signal Transduction, NF-kappa B, Apoptosis, Reactive Oxygen Species, Receptors, Tumor Necrosis Factor, MAP Kinase Kinase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.